Advanced Forum ViewPharmaceutical Jobs Healthcare Social Network

Forum Topic News

Search in the sub-forums

News

503 conversations, 505 comments, 44,355 views

- Latest Comments
  
  Comments/Views
  
  Conversations
- by PHARMeMED
  
  February 7, 2019
  
  1 / 2,546
  
  Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
  
  Posted on February 7, 2019 by PHARMeMED
  
  by PHARMeMED
  
  February 4, 2019
  
  1 / 2,529
  
  Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global Scientific Meeting
  
  Posted on February 4, 2019 by PHARMeMED
  
  by PHARMeMED
  
  February 1, 2019
  
  1 / 2,442
  
  Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retina...
  
  Posted on February 1, 2019 by PHARMeMED
  
  by PHARMeMED
  
  February 1, 2019
  
  1 / 2,573
  
  FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the F...
  
  Posted on February 1, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 30, 2019
  
  1 / 2,527
  
  See 20+ case studies of pharma creating value for patients and healthcare
  
  Posted on January 30, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 25, 2019
  
  1 / 2,544
  
  Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
  
  Posted on January 25, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 23, 2019
  
  1 / 2,574
  
  Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multiple System Atrophy
  
  Posted on January 23, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 21, 2019
  
  1 / 2,463
  
  Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirum...
  
  Posted on January 21, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 9, 2019
  
  1 / 2,546
  
  EVENITY™ (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
  
  Posted on January 9, 2019 by PHARMeMED
  
  by PHARMeMED
  
  January 6, 2019
  
  1 / 2,511
  
  Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administrat...
  
  Posted on January 6, 2019 by PHARMeMED
  
  by PHARMeMED
  
  December 14, 2018
  
  1 / 2,652
  
  FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
  
  Posted on December 14, 2018 by PHARMeMED
  
  by PHARMeMED
  
  December 13, 2018
  
  1 / 2,530
  
  16S Next Generation Sequencing Bacterial Meningitis test from Viracor Eurofins provides actionable results to improve patient ou...
  
  Posted on December 13, 2018 by PHARMeMED
  
  by PHARMeMED
  
  December 10, 2018
  
  1 / 2,636
  
  Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
  
  Posted on December 10, 2018 by PHARMeMED
  
  by PHARMeMED
  
  December 4, 2018
  
  1 / 2,586
  
  CAR T-Cell Treatment
  
  Posted on December 4, 2018 by PHARMeMED
  
  by PHARMeMED
  
  December 3, 2018
  
  1 / 2,653
  
  FDA approves first treatment for Lambert-Eaton myasthenic syndrome (LEMS) in adults
  
  Posted on December 3, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 28, 2018
  
  1 / 2,590
  
  Advancing Clinical Trials Endeavoring to Improve Odds Against Pancreatic Cancer
  
  Posted on November 28, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 26, 2018
  
  1 / 2,583
  
  Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Tre...
  
  Posted on November 26, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 21, 2018
  
  1 / 2,582
  
  Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
  
  Posted on November 21, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 20, 2018
  
  1 / 2,505
  
  Researchers Use MRI to Predict Alzheimer's Disease
  
  Posted on November 20, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 20, 2018
  
  1 / 2,745
  
  Applied BioMath, LLC Announces Collaboration with Obsidian Therapeutics for Semi-Mechanistic Quantitative Modeling of a Novel Th...
  
  Posted on November 20, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 19, 2018
  
  1 / 2,554
  
  Philips Debuts Noninvasive Ventilator With High Flow Therapy to Improve Patient Care
  
  Posted on November 19, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 16, 2018
  
  1 / 2,533
  
  Vyera Pharmaceuticals Receives FDA Clearance To Initiate A Phase 1 Study Of A New Chemical Entity Designed As A Potential Treatm...
  
  Posted on November 16, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 14, 2018
  
  1 / 2,730
  
  Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Desi...
  
  Posted on November 14, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 14, 2018
  
  1 / 2,565
  
  FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
  
  Posted on November 14, 2018 by PHARMeMED
  
  by PHARMeMED
  
  November 13, 2018
  
  1 / 2,630
  
  Evox Therapeutics Wins Funding From Duchenne UK to Explore Exosome-Mediated Delivery of Dystrophin
  
  Posted on November 13, 2018 by PHARMeMED
  Mark All as Read
  
  Quick navigation
  « Previous
  
  4
  
  5
  
  6
  
  7
  
  8
  
  9
  
  10
  
  11
  
  12
  
  13
  
  Next »

Sign In or Join

News